Ascletis Pharma Inc. (1672.HK)

HKD 2.55

(-10.21%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.49 Billion 2.65 Billion 2.82 Billion 3.06 Billion 3.42 Billion 3.52 Billion
Total Current Assets 2.33 Billion 2.54 Billion 2.63 Billion 2.82 Billion 3.19 Billion 3.36 Billion
Cash And Short Term Investments 2.29 Billion 2.48 Billion 2.5 Billion 2.71 Billion 2.98 Billion 3.17 Billion
Cash and Cash Equivalents 330.11 Million 2.47 Billion 2.49 Billion 2.71 Billion 2.98 Billion 3.17 Billion
Short Term Investments 1.96 Billion 11.2 Million 5.2 Million 2.2 Million 4.78 Million 1.66 Million
Net Receivables 5.43 Million 23.87 Million 53.6 Million 26.62 Million 69.52 Million 57.62 Million
Inventory 6.07 Million 20.51 Million 56.23 Million 58.89 Million 86.03 Million 83.87 Million
Other Current Assets 42.83 Million 26.85 Million 23.62 Million 28.25 Million 43.05 Million 106.21 Million
Total Non-Current Assets 158.25 Million 112.31 Million 198.4 Million 237.08 Million 233.81 Million 164.26 Million
Net PPE 68.53 Million 73.04 Million 77.92 Million 84.57 Million 98.72 Million 88.59 Million
Good Will And Intangible Assets 26.31 Million 16.55 Million 78.21 Million 90.7 Million 75.61 Million 75.4 Million
Good Will - - - - - -
Intangible Assets 26.31 Million 16.55 Million 78.21 Million 90.7 Million 75.61 Million 75.4 Million
Long-Term Investments 63.02 Million 10.81 Million 36.65 Million 60.91 Million 58.1 Million -
Tax Assets -261 Thousand -10.81 Million - -60.91 Million -58.1 Million -
Other Non Current Assets 637 Thousand 22.71 Million 5.61 Million 61.8 Million 59.47 Million 275 Thousand
Other Assets - - - - - -
Total Liabilities 148.94 Million 117.15 Million 100.88 Million 85.42 Million 102.17 Million 100.19 Million
Total Current Liabilities 140.67 Million 108.18 Million 90.97 Million 73.77 Million 87.65 Million 93.4 Million
Account Payables 649 Thousand 3.13 Million 1.05 Million 930 Thousand 6.64 Million 14.19 Million
Tax Payables 1.72 Million 1.55 Million 3.95 Million 659 Thousand 1.61 Million 371 Thousand
Short Term Debt 5.71 Million 2.41 Million 1.56 Million 1.14 Million 2.22 Million -
Deferred Revenue -5.71 Million - - - - -
Other Current Liabilities 140.03 Million 102.63 Million 88.34 Million 71.69 Million 78.78 Million 79.21 Million
Total Non Current Liabilities 8.26 Million 8.96 Million 9.91 Million 11.65 Million 14.51 Million 6.78 Million
Long-Term Debt 2.7 Million 1.82 Million 1.18 Million 443 Thousand 1.58 Million -
Deferred Revenue Non Current 5.55 Million 7.14 Million 8.73 Million 11.2 Million 12.93 Million 6.78 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 5.55 Million 7.14 Million 8.73 Million 11.2 Million 12.93 Million -
Other Liabilities - - - - - -
Total Equity 2.34 Billion 2.53 Billion 2.72 Billion 2.98 Billion 3.32 Billion 3.42 Billion
Stock Holders Equity 2.34 Billion 2.53 Billion 2.72 Billion 2.98 Billion 3.32 Billion 3.42 Billion
Common Stock 731 Thousand 742 Thousand 746 Thousand 750 Thousand 754 Thousand 764 Thousand
Retained Earnings -1.17 Billion -1.02 Billion -714.84 Million -515.82 Million -306.58 Million -210.61 Million
Accumulated other comprehensive income 2.34 Billion 702 Million 578.32 Million 603.19 Million 716.91 Million -8.63 Million
Common Stock Equity 2.34 Billion 2.53 Billion 2.72 Billion 2.98 Billion 3.32 Billion 3.42 Billion
Capital Lease Obligation 8.41 Million 4.23 Million 2.75 Million 1.58 Million 3.81 Million -
Total Investments 63.02 Million 22.01 Million 41.85 Million 60.91 Million 58.1 Million 1.66 Million
Total Debt 8.41 Million 4.23 Million 2.75 Million 1.58 Million 3.81 Million -
Net Debt -321.7 Million -2.46 Billion -2.49 Billion -2.71 Billion -2.98 Billion -3.17 Billion

Balance Sheet Charts